Cerebral thromboembolic events in pediatric patients with inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 16, Issue 4, 2010, Pages 677-683

  Barclay, Andrew R ^a   Keightley, J M ^b   Horrocks, I ^b   Garrick, V ^b   McGrogan, P ^b   Russell, R K ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

Children; Inflammatory bowel disease; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; AZATHIOPRINE; C REACTIVE PROTEIN; CEFOTAXIME; CYCLOSPORIN; HEMOGLOBIN; INFLIXIMAB; INFUSION FLUID; IRON; LOW MOLECULAR WEIGHT HEPARIN; MANNITOL; METHOTREXATE; METHYLPREDNISOLONE; MORPHINE; MULTIVITAMIN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; PREDNISONE; RANITIDINE; SALAZOSULFAPYRIDINE; STEROID; WARFARIN;

ADOLESCENT; ANEMIA; ARM SWELLING; AROUSAL; ARTICLE; ATAXIA; BLOOD TRANSFUSION; CEREBRAL THROMBOEMBOLIC EVENT; CHILD; COLON CROHN DISEASE; COLON RESECTION; CROHN DISEASE; DEMOGRAPHY; DIARRHEA; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENTERIC FEEDING; ENTERITIS; ERYTHROCYTE SEDIMENTATION RATE; FECES INCONTINENCE; FEMALE; GLASGOW COMA SCALE; HEADACHE; HEMIPLEGIA; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; IMMOBILIZATION; INTRACRANIAL HYPERTENSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; MEMORY DISORDER; MENTAL CONCENTRATION; MENTAL INSTABILITY; MORBIDITY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OCCLUSIVE CEREBROVASCULAR DISEASE; ORAL CONTRACEPTION; OUTCOME ASSESSMENT; PARENTERAL NUTRITION; PARESTHESIA; PHYSICAL DISEASE; PHYSIOTHERAPY; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCHOOL CHILD; SHORT TERM MEMORY; SLEEP DISORDER; SMOKING; STROKE; THROMBOCYTE COUNT; THROMBOEMBOLISM; ULCERATIVE COLITIS; VOMITING; WEIGHT REDUCTION;

ADOLESCENT; CHILD; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; INCIDENCE; INTRACRANIAL THROMBOSIS; MAGNETIC RESONANCE IMAGING; MALE; PROGNOSIS; RISK FACTORS;

EID: 77949519618     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21113     Document Type: Article

References (48)

1. Beattie RM, Croft NM, Fell JM, et al. Inflammatory bowel disease. Arch Dis Child. 2006;91:426-432.
2. Silverberg MS, Daly MJ, Diagnostic misclassification reduces the ability to detect linkage in inflammatory bowel disease genetic studies. Gut. 2001;49:773-776.
3. Twig G, Zandman-Goddard G, Szyper-Kravitz M, et al. Systemic thromboembolism in inflammatory bowel disease: mechanisms and clinical applications. Ann N Y Acad Sci. 2005;1051:166-173.
4. Loftus EV, Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504-1517.
5. Armitage E, Drummond H, Ghosh S, et al. Incidence of juvenile-onset Crohn's disease in Scotland. Lancet. 1999;353:1496-1497.
6. Lynch JK. Cerebrovascular disorders in children. Curr Neurol Neurosci Rep. 2004;4:129-138.
7. Lloyd-Still JD, Tomasi L. Neurovascular and thromboembolic complications of inflammatory bowel disease in childhood. J Pediatr Gastroenterol Nutr. 1989;9:461-466.
8. Standridge S, de los Reyes E. Inflammatory bowel disease and cerebrovascular arterial and venous thromboembolic events in 4 pediatric patients: a case series and review of the literature. J Child Neurol. 2008;23:59-66.
9. Silverberg MS, Satsangi J, Ahmad T, et al. Towards an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19:5-36.
10. Calderon A, Wong JW, Becker LE. Multiple cerebral venous thromboses in a child with ulcerative colitis. Clin Pediatr (Phila). 1993;32:169-171.
11. Fukuhara T, Tsuchida S, Kinugasa K, et al. A case of pontine lacunar infarction with ulcerative colitis. Clin Neurol Neurosurg. 1993;95: 159-162.
12. Keene DL, Matzinger MA, Jacob PJ, et al. Cerebral vascular events associated with ulcerative colitis in children. Pediatr Neurol. 2001;24: 238-243.
13. Markowitz RL, Ment LR, Gryboski JD. Cerebral thromboembolic disease in pediatric and adult inflammatory bowel disease: case report and review of the literature. J Pediatr Gastroenterol Nutr. 1989;8: 413-420.
14. Mayeux R, Fahn S. Strokes and ulcerative colitis. Neurology. 1978; 28:571-574.
15. Nelson J, Barron MM, Riggs JE, et al. Cerebral vasculitis and ulcerative colitis. Neurology. 1986;36:719-721.
16. Paradis K, Bernstein ML, Adelson JW. Thrombosis as a complication of inflammatory bowel disease in children: a report of four cases. J Pediatr Gastroenterol Nutr. 1985;4:659-662.
17. Patterson M, Castiglioni L, Sampson L. Chronic ulcerative colitis beginning in children and teenagers. A review of 43 patients. Am J Dig Dis. 1971;16:289-297.
18. Rousseau B, Belanger C, Lacoursiere Y, et al. [Ulcerative colitis and cerebral venous thrombosis.] Union Med Can. 1975;104:414-417.
19. Schneiderman JH, Sharpe JA, Sutton DM. Cerebral and retinal vascular complications of inflammatory bowel disease. Ann Neurol. 1979;5: 331-337.
20. Tomomasa T, Itoh K, Matsui A, et al. An infant with ulcerative colitis complicated by endocarditis and cerebral infarction. J Pediatr Gastroenterol Nutr. 1993;17:323-325.
21. Yassinger S, Adelman R, Cantor D, et al. Association of inflammatory bowel disease and large vascular lesions. Gastroenterology. 1976;71: 844-846.
22. Hommes DW, van Dullemen HM, Levi M, et al. Beneficial effect of treatment with a monoclonal anti-tumor necrosis factor-alpha antibody on markers of coagulation and fibrinolysis in patients with active Crohn's disease. Haemostasis. 1997;27:269-277.
23. Brynskov J, Nielsen OH, Ahnfelt-Ronne I, et al. Cytokines (immunoinflammatory hormones) and their natural regulation in inflammatory bowel disease (Crohn's disease and ulcerative colitis): a review. Dig Dis. 1994;12:290-304.
24. Grainge MJ, West J, Card TR. Risk of pulmonary embolism and deep vein thrombosis during episodes of acute flare, chronic activity and remission in inflammatory bowel disease. Gut. 2008;57(suppl II):A16.
25. Jackson LM, O'Gorman PJ, O'Connell J, et al. Thrombosis in inflammatory bowel disease: clinical setting, procoagulant profile and factor V Leiden. QJM. 1997;90:183-188.
26. Solem CA, Loftus EV, Tremaine WJ, et al. Venous thromboembolism in inflammatory bowel disease. Am J Gastroenterol. 2004;99:97-101.
27. Miehsler W, Reinisch W, Valic E, et al. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut. 2004;53:542-548.
28. Thompson NP, Wakefield AJ, Pounder RE. Inherited disorders of coagulation appear to protect against inflammatory bowel disease. Gastroenterology. 1995;108:1011-1015.
29. Faioni EM, Ferrero S, Fontana G, et al. Expression of endothelial protein C receptor and thrombomodulin in the intestinal tissue of patients with inflammatory bowel disease. Crit Care Med. 2004;32: S266-S270.
30. Koutroubakis IE, Petinaki E, Anagnostopoulou E, et al. Anti-cardiolipin and anti-beta2-glycoprotein I antibodies in patients with inflammatory bowel disease. Dig Dis Sci. 1998;43:2507-2512.
31. Oldenburg B, Fijnheer R, van der GR, et al. Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications? Am J Gastroenterol. 2000;95:2825-2830.
32. Webberley MJ, Hart MT, Melikian V. Thromboembolism in inflammatory bowel disease: role of platelets. Gut. 1993;34:247-251.
33. Yoshida H, Grainger DN. Inflammatory bowel disease: a paradigm for the link between coagulation and inflammation. Inflamm Bowel Dis. 2009;15:1245-1255.
34. Novacek G, Miehsler W, Kapiotis S, et al. Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease. Am J Gastroenterol. 1999;94:685-690.
35. Toruner M, Erkan O, Soykan I, et al. Factor V Leiden, prothrombin G20210A and MTHFR gene mutations in inflammatory bowel disease. Turk J Gastroenterol. 2004;15:250-252.
36. Nguyen GC, Sam J. Diagnostic misclassification reduces the ability to detect linkage in inflammatory bowel disease genetic studies. Am J Gastroenterol. 2008;103:2272-2280.
37. Novacek G, Weltermann A, Sobala A, et al. Increased risk of recurrent venous thrombosis in inflammatory bowel disease. Gut. 2008; 40(suppl 1):A16.
38. Saibeni S, Cattaneo M, Vecchi M, et al. Low vitamin B(6) plasma levels, a risk factor for thrombosis, in inflammatory bowel disease: role of inflammation and correlation with acute phase reactants. Am J Gastroenterol. 2003;98:112-117.
39. Younes-Mhenni S, Derex L, Berruyer M, et al. Large-artery stroke in a young patient with Crohn's disease. Role of vitamin B6 deficiency-induced hyperhomocysteinemia. J Neurol Sci. 2004;221:113-115.
40. Wakefield AJ, Sawyerr AM, Hudson M, et al. Smoking, the oral contraceptive pill, and Crohn's disease. Dig Dis Sci. 1991;36: 1147-1150.
41. Lissner D, Reinisch W, Papay P, et al. Exposure to passive smoking during childhood irrevervsibly increases the risk for surgery in patients with Crohn's disease. Gut. 2008;57(suppl II):A57.
42. Ageno W, Squizzato A, Ambrosini F, et al. Thrombosis prophylaxis in medical patients: a retrospective review of clinical practice patterns. Haematologica. 2002;87:746-750.
43. Vrij AA, Jansen JM, Schoon EJ, et al. Low molecular weight heparin treatment in steroid refractory ulcerative colitis: clinical outcome and influence on mucosal capillary thrombi. Scand J Gastroenterol Suppl. 2001;41-47.
44. Vande Griend JP, Saseen JJ. Combination antiplatelet agents for secondary prevention of ischemic stroke. Pharmacotherapy. 2008;28: 1233-1242.
45. Monagle P, Chan A, Massicotte P, et al. Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:645S-687S.
46. Paediatric stroke working group (RCP). Stroke in childhood: clinical guidelines for diagnosis, rehabilitation and management. June 2008.
47. Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr. 1991;12:439-447.
48. Turner D, Walsh CM, Benchimol EI, et al. Severe paediatric ulcerative colitis: incidence, outcomes and optimal timing for second-line therapy. Gut. 2008;57:331-338.